Abstract:Due to the poor permeability across Gram-negative bacterial membranes and the troublesome bacterial efflux mechanism, only a few GyrB/ParE inhibitors with potent activity against Gram-negative pathogens have been reported. Among them, pyrimido[4,5-b]indole derivatives represented by GP-1 demonstrated excellent broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria but were limited by hERG inhibition and poor pharmacokinetics profile. To improve their drug-like properties, we designed a series of novel pyrimido[4,5-b]indole derivatives based on the tricyclic scaffold of GP-1 and the C-7 moiety of acorafloxacin. These efforts have culminated in the discovery of a promising compound 18r with reduced hERG liability and an improved PK profile. Compound 18r exhibited superior broad-spectrum in vitro antibacterial activity compared to GP-1, including a variety of clinical multidrug G– pathogens, especially Acinetobacter baumannii, and the in vivo efficacy was also demonstrated in a neutropenic mouse thigh model of infection with multidrug-resistant A. baumannii.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00621?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00621</a>.More MIC data and details of tested compounds for <a class="ref showTableEvent internalNav" href="#tbl1">Tables </a><a class="ref showTableEvent internalNav" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" href="#tbl4">4</a>; more MIC data and details of tested compounds for <a class="ref showTableEvent internalNav" href="#tbl5">Table </a><a class="ref showTableEvent internalNav" href="#tbl5">5</a>; metabolite identification of compound 18k in rat liver microsomes; proposed metabolic pathways of compound 18k; preparation and characterization data of all intermediates; NMR spectra and HRMS data of final compounds; and HPLC traces for lead compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00621/suppl_file/jm1c00621_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00621/suppl_file/jm1c00621_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Virtual screening and biological activity evaluation of novel efflux pump inhibitors targeting AdeB

The Relationship Between AdeB Efflux System of Multidrug Resistant Acinetobacter Baumannii and Carbapenem Resistance

Discovery of 2-Aminothiazolyl Berberine Derivatives As Effectively Antibacterial Agents Toward Clinically Drug-Resistant Gram-negative Acinetobacter Baumanii.

Discovery of novel BfmR inhibitors restoring carbapenem susceptibility against carbapenem-resistant Acinetobacter baumannii by structure-based virtual screening and biological evaluation

Integrated computer-aided drug design and biophysical simulation approaches to determine natural anti-bacterial compounds for Acinetobacter baumannii

Synthesis and antibiofilm evaluation of N-acyl-2-aminopyrimidine derivatives against Acinetobacter baumannii

Repurposing FDA-approved drugs for combating tigecycline resistance in Acinetobacter baumannii: in silico screening against BaeR protein

Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach

Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance

New antibacterial candidates against Acinetobacter baumannii discovered by in silico-driven chemogenomics repurposing

A Novel Chemical Biology and Computational Approach to Expedite the Discovery of New-Generation Polymyxins Against Life-Threatening Acinetobacter Baumannii

Novel berberine derivatives as adjuvants in the battle against Acinetobacter baumannii: A promising strategy for combating multi-drug resistance

Novel Coumarins Derivatives for A. baumannii Lung Infection Developed by High-Throughput Screening and Reinforcement Learning

High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae

Design, Synthesis, and Biological Evaluation of Novel Pyrimido[4,5- b ]indole Derivatives Against Gram-Negative Multidrug-Resistant Pathogens

Discovery of Adjuvants with Antibacterial Potentiation Activity Against Carbapenemase-Producing Enterobacterales Based on in Silico Virtual Screening.

Virtual screening of plant‐derived molecules against zinc‐dependent imipenemases in class B metallo‐β‐lactamases of Acinetobacter baumannii

Inhibitors of Bacterial Efflux Pumps as Adjuvants in Antibiotic Treatments and Diagnostic Tools for Detection of Resistance by Efflux

Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

Targeting PilA in Acinetobacter baumannii: A Computational Approach for Anti-Virulent Compound Discovery

Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii: From Screening Impurity to In Vivo Efficacy